Why the study?
Does smoking cessation reduce secondary cardiovascular disease events in patients following an acute coronary syndrome or coronary artery revascularization?
Population
967 participants of an in-patient 3-week rehabilitation programme following an acute coronary syndrome or…
Comparison
Smoking cessation or non-smoking assessed by… vs Continued smokers (cotinine-positive subjects)
Design
Cohort
Follow-up
1 year
Authors
Loading...
Supports cotinine-verified cessation post-ACS; leaves open whether RCTs confirm reduced secondary events.
Does smoking cessation reduce secondary cardiovascular disease events in patients following an acute coronary syndrome or coronary artery revascularization?
Smoking cessation, especially when verified by serum cotinine, is associated with a significantly reduced risk of secondary cardiovascular events at 1 year post-ACS or revascularization.
Twardella et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: